88 results
10-K
2023 FY
EX-10.17
FBRX
Forte Biosciences Inc
Annual report
18 Mar 24
4:20pm
10-K
2023 FY
EX-10.16
FBRX
Forte Biosciences Inc
Annual report
18 Mar 24
4:20pm
8-K
EX-10.1
FBRX
Forte Biosciences Inc
20 Sep 23
Departure of Directors or Certain Officers
4:15pm
8-K
EX-10.2
FBRX
Forte Biosciences Inc
1 Aug 23
Forte Biosciences, Inc. Announces $25 Million Financing and R&D Update for FB-102
4:06pm
8-K
EX-10.1
FBRX
Forte Biosciences Inc
1 Aug 23
Forte Biosciences, Inc. Announces $25 Million Financing and R&D Update for FB-102
4:06pm
8-K
EX-10.1
osz7eq2i8jbp
31 Mar 22
Entry into a Material Definitive Agreement
8:57pm
8-K
EX-10.1
gf5n1h6eha8ljvi
4 Sep 20
Audited Financial Statements
4:31pm
S-8
EX-10.2
76o8l ag3
11 Aug 20
Registration of securities for employees
5:19pm
S-8
EX-10.1
mcz2lab
11 Aug 20
Registration of securities for employees
5:19pm
8-K
EX-10.1
4ka uxle6ags74k7
15 Jun 20
Forte Biosciences, Inc. Announces Closing of Merger with Tocagen
5:21pm
S-4/A
EX-10.19
jr3qp92z5tak0otpk
27 Apr 20
Registration of securities issued in business combination transactions (amended)
6:27am
S-4/A
EX-10.18
ddoqp689j01qpscl91
27 Apr 20
Registration of securities issued in business combination transactions (amended)
6:27am